FUJIFILM Diosynth Biotechnologies announced that Janssen Supply Group, LLC, a Johnson & Johnson company, has committed to a large-scale manufacturing suite at its biopharmaceutical manufacturing facility in Holly Springs, which is set to be fully operational in 2025. This long-term commitment is an extension of an existing relationship and will support manufacturing of Janssen?s clinical and commercial pipeline.